Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study

详细信息    查看全文

• 作者：Leong L. Ng ; MD^a ; ^b ; ^{lln1@le.ac.uk} ; Iain B. Squire ; MD^a ; ^b ; Donald J.L. Jones ; PhD^c ; Thong Huy Cao ; MD ; PhD^a ; ^b ; Daniel C.S. Chan ; BMedSci ; BM BS^a ; ^b ; Jatinderpal K. Sandhu ; MPhil^a ; ^b ; Paulene A. Quinn ; MPhil^a ; ^b ; Joan E. Davies ; PhD^a ; ^b ; Joachim Struck ; PhD^d ; Oliver Hartmann ; PhD^d ; Andreas Bergmann ; PhD^d ; Alexandre Mebazaa ; MD ; PhD^e ; Etienne Gayat ; PhD^e ; Mattia Arrigo ; MD^e ; Eiichi Akiyama ; MD^e ; Zaid Sabti ; MD^f ; Jens Lohrmann ; MD^f ; Raphael Twerenbold ; MD^f ; Thomas Herrmann ; MD^f ; Carmela Schumacher ; MSc^f ; Nikola Kozhuharov ; MD^f ; Christian Mueller ; MD^f ; on behalf of the GREAT Network
• 关键词：acute kidney injury ; B-type natriuretic peptide ; mortality ; net reclassification improvement ; opioids
• 刊名：Journal of the American College of Cardiology
• 出版年：2017
• 出版时间：3-10 January 2017
• 年：2017
• 卷：69
• 期：1
• 页码：56-69
• 全文大小：762 K
• 卷排序：69

文摘

Proenkephalin A (PENK) and its receptors are widely distributed. Enkephalins are cardiodepressive and difficult to measure directly. PENK is a stable surrogate analyte of labile enkephalins that is correlated inversely with renal function. Cardiorenal syndrome is common in acute heart failure (HF) and portends poor prognosis.ObjectivesThis study assessed the prognostic value of PENK in acute HF, by identifying levels that may be useful in clinical decisions, and evaluated its utility for predicting cardiorenal syndrome.MethodsThis multicenter study measured PENK in 1,908 patients with acute HF (1,186 male; mean age 75.66 &plusmn; 11.74 years). The primary endpoint was 1-year all-cause mortality; secondary endpoints were in-hospital mortality, all-cause mortality or HF rehospitalization within 1 year, and in-hospital worsening renal function, defined as a rise in plasma creatinine ≥26.5 μmol/l or 50% higher than the admission value within 5 days of presentation.ResultsDuring 1-year follow-up, 518 patients died. Measures of renal function were the major determinants of PENK levels. PENK independently predicted worsening renal function (odds ratio: 1.58; 95% confidence interval [CI]: 1.24 to 2.00; p < 0.0005) with a model receiver-operating characteristic area of 0.69. PENK was associated with the degree of worsening renal function. Multivariable Cox regression models showed that PENK level was an independent predictor of 1-year mortality (p < 0.0005) and 1-year death and/or HF (hazard ratio: 1.27; 95% CI: 1.10 to 1.45; p = 0.001). PENK levels independently predicted outcomes at 3 or 6 months and were independent predictors of in-hospital mortality, predominantly down-classifying risk in survivors when added to clinical scores; levels <133.3 pmol/l and >211.3 pmol/l detected low-risk and high-risk patients, respectively.ConclusionsPENK levels reflect cardiorenal status in acute HF and are prognostic for worsening renal function and in-hospital mortality as well as mortality during follow-up.